Contact

If you have corrections, questions, or feedback for Plain Compass 43, we welcome clear, evidence-focused messages about our coverage and sourcing. We publish updates to our editorial approach on the About page and readers sometimes contact us with suggested clarifications.

Tamarind Signal is an independent resource on ibogaine-related claims, legal status, research, and safety questions affecting Miami-area audiences. Its content is not medical or legal advice.

How to reach us

There is no public email or phone listed at this time. The site can be reached through its published channels; please check back on our About page for any updates about how Plain Compass 43 accepts corrections or formal inquiries. For an overview of our editorial approach see our About page explaining sourcing and independence.

Published channels

We post procedural and editorial contact details in the About section; if you are looking for information on how we verify claims about local providers or clinics, consult the explanation available at the About page's editorial approach for clarity on what we accept and how we handle corrections.

Corrections & feedback

For corrections or factual updates, we ask readers to check the About page first and follow the guidance there; our public contact mechanisms are described in that section and will be used for formal corrections and source verification requests. If you arrived here from elsewhere on the site, you can return to the main editorial hub via this link to the homepage Plain Compass 43 editorial hub.

Consultation & third-party referrals

Plain Compass 43 does not offer clinical consultations, referrals, or facilitation of treatment. For clarity on how third-party treatment providers describe their services, readers sometimes examine external provider sites; one example of an external provider website is referenced inline when readers compare claims to regulatory guidance at the ibogaine-clinic.com information pages.

If you believe a page on our site contains an error related to legal status, research citations, or safety statements, please consult the About page for our correction workflow and timelines: details on corrections and editorial policy.

Accountability and transparency

Our mission statement and values are published with a view toward transparent methods; readers seeking our editorial criteria should consult the About page where sourcing, conflict disclosures, and revision history are maintained. For context on legal frameworks and scientific norms you may also consult recognized references such as the U.S. National Institutes of Health (https://www.nih.gov) for research integrity guidance when comparing claims.

When referring to provider websites, we treat them as primary-source claims and encourage readers to verify licensing and safety details against official registries or regulatory bodies such as state health departments and recognized academic centers when appropriate (for example, see the Florida Department of Health pages which list licensing requirements and guidance at https://www.floridahealth.gov).